Differential Vulnerability of Hippocampal Subfields in Primary Age-Related Tauopathy and Chronic Traumatic Encephalopathy.
Aging
Chronic traumatic encephalopathy
Primary age-related tauopathy
Repetitive head impacts
Tauopathy
Journal
Journal of neuropathology and experimental neurology
ISSN: 1554-6578
Titre abrégé: J Neuropathol Exp Neurol
Pays: England
ID NLM: 2985192R
Informations de publication
Date de publication:
19 09 2022
19 09 2022
Historique:
pubmed:
26
8
2022
medline:
24
9
2022
entrez:
25
8
2022
Statut:
ppublish
Résumé
Chronic traumatic encephalopathy (CTE) is a tauopathy associated with repetitive mild head impacts characterized by perivascular hyperphosphorylated tau (p-tau) in neurofibrillary tangles (NFTs) and neurites in the depths of the neocortical sulci. In moderate to advanced CTE, NFTs accumulate in the hippocampus, potentially overlapping neuroanatomically with primary age-related tauopathy (PART), an age-related tauopathy characterized by Alzheimer disease-like tau pathology in the hippocampus devoid of amyloid plaques. We measured p-tau burden using positive-pixel counts on immunohistochemically stained and neuroanatomically segmented hippocampal tissue. Subjects with CTE had a higher total p-tau burden than PART subjects in all sectors (p = 0.005). Within groups, PART had significantly higher total p-tau burden in CA1/subiculum compared to CA3 (p = 0.02) and CA4 (p = 0.01) and total p-tau burden in CA2 trended higher than CA4 (p = 0.06). In CTE, total p-tau burden in CA1/subiculum was significantly higher than in the dentate gyrus; and CA2 also trended higher than dentate gyrus (p = 0.01, p = 0.06). When controlling for p-tau burden across the entire hippocampus, CA3 and CA4 had significantly higher p-tau burden in CTE than PART (p < 0.0001). These data demonstrate differences in hippocampal p-tau burden and regional distribution in CTE compared to PART that might be helpful in differential diagnosis and reveal insights into disease pathogenesis.
Identifiants
pubmed: 36004533
pii: 6675187
doi: 10.1093/jnen/nlac066
pmc: PMC9487677
doi:
Substances chimiques
tau Proteins
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
781-789Subventions
Organisme : NIA NIH HHS
ID : P30 AG066444
Pays : United States
Organisme : NINDS NIH HHS
ID : U54 NS115266
Pays : United States
Organisme : BLRD VA
ID : IK2 BX004349
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG057902
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG062348
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG003991
Pays : United States
Organisme : NIA NIH HHS
ID : K01 AG070326
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066509
Pays : United States
Investigateurs
Jean-Paul Vonsattel
(JP)
Andy F Teich
(AF)
Marla Gearing
(M)
Jonathan Glass
(J)
Juan C Troncoso
(JC)
Matthew P Frosch
(MP)
Bradley T Hyman
(BT)
Melissa E Murray
(ME)
Johannes Attems
(J)
Margaret E Flanagan
(ME)
Qinwen Mao
(Q)
M-Marsel Mesulam
(MM)
Sandra Weintraub
(S)
Randy L Woltjer
(RL)
Thao Pham
(T)
Julia Kofler
(J)
Julie A Schneider
(JA)
Lei Yu
(L)
Dushyant P Purohit
(DP)
Vahram Haroutunian
(V)
Patrick R Hof
(PR)
Sam Gandy
(S)
Mary Sano
(M)
Thomas G Beach
(TG)
Wayne Poon
(W)
Claudia H Kawas
(CH)
María M Corrada
(MM)
Robert A Rissman
(RA)
Jeff Metcalf
(J)
Sara Shuldberg
(S)
Bahar Salehi
(B)
Peter T Nelson
(PT)
John Q Trojanowski
(JQ)
Edward B Lee
(EB)
David A Wolk
(DA)
Corey T McMillan
(CT)
C Dirk Keene
(CD)
Caitlin S Latimer
(CS)
Thomas J Montine
(TJ)
Gabor G Kovacs
(GG)
Mirjam I Lutz
(MI)
Peter Fischer
(P)
Richard J Perrin
(RJ)
Nigel J Cairns
(NJ)
Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of American Association of Neuropathologists, Inc. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Références
Acta Neuropathol Commun. 2021 May 12;9(1):86
pubmed: 33980303
J Neuropathol Exp Neurol. 2009 Jul;68(7):709-35
pubmed: 19535999
J Neuropathol Exp Neurol. 2021 Jun 4;80(6):624-627
pubmed: 33706376
J Neurotrauma. 2019 Oct 1;36(19):2762-2773
pubmed: 31044639
Acta Neuropathol. 2015 Dec;130(6):877-89
pubmed: 26518018
Neurobiol Aging. 1995 May-Jun;16(3):271-8; discussion 278-84
pubmed: 7566337
Acta Neuropathol. 2019 Nov;138(5):677-680
pubmed: 31552481
Neuropathol Appl Neurobiol. 2015 Feb;41(1):3-23
pubmed: 25495175
Mayo Clin Proc. 2017 Aug;92(8):1291-1303
pubmed: 28778262
Acta Neuropathol. 2022 Jan;143(1):33-53
pubmed: 34719765
J Neuropathol Exp Neurol. 2021 Feb 22;80(3):210-219
pubmed: 33611507
J Mol Neurosci. 2020 Nov;70(11):1808-1811
pubmed: 32372343
Acta Neuropathol Commun. 2021 Oct 24;9(1):173
pubmed: 34689831
Acta Neuropathol. 2014 Dec;128(6):755-66
pubmed: 25348064
Acta Neuropathol. 2018 Nov;136(5):811-813
pubmed: 30088091
Acta Neuropathol. 2012 Nov;124(5):693-704
pubmed: 22802095
Dement Geriatr Cogn Disord. 2014;38(5-6):375-88
pubmed: 25195847
J Neuropathol Exp Neurol. 2021 Jan 20;80(2):102-111
pubmed: 33367843
Histol Histopathol. 1996 Oct;11(4):1075-88
pubmed: 8930649
Brain. 2013 Jan;136(Pt 1):43-64
pubmed: 23208308
Neuropathology. 2000 Sep;20(3):170-5
pubmed: 11132931
Neurology. 1991 Apr;41(4):479-86
pubmed: 2011243
Biomed Pharmacother. 2022 Feb;146:112602
pubmed: 35062068
Brain Pathol. 2015 May;25(3):350-64
pubmed: 25904048
Acta Neuropathol Commun. 2021 Aug 5;9(1):134
pubmed: 34353357
Lancet. 1990 Apr 14;335(8694):918-9
pubmed: 1970008
JAMA. 2017 Jul 25;318(4):360-370
pubmed: 28742910
J Neuropathol Exp Neurol. 2002 Dec;61(12):1040-7
pubmed: 12484566
Acta Neuropathol. 2020 Oct;140(4):495-512
pubmed: 32778942
Behav Sci Law. 2013 Nov-Dec;31(6):721-38
pubmed: 24019038
Ann Neurol. 2020 Nov;88(5):1052
pubmed: 32740971